BRIEF published on 11/24/2025 at 06:35, 2 months 15 days ago Formycon Partners with NTC for Biosimilar Commercialization in Italy Formycon AG Ophthalmology Biosimilar Partnerships Italy Pharmaceutical Market FYB203/Baiama®
PRESS RELEASE published on 11/24/2025 at 06:30, 2 months 15 days ago NTC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/Baiama® in Italy Formycon AG partners with NTC for Eylea biosimilar commercialization in Italy. Agreement includes royalties and supply chain organization Italy Formycon AG Commercialization Eylea Biosimilar NTC
BRIEF published on 11/20/2025 at 17:05, 2 months 18 days ago First Berlin réaffirme sa recommandation d'achat sur Formycon AG Formycon AG Dupixent Évaluation D'achat Prévisions De Recettes Biosimilaire De Keytruda
BRIEF published on 11/20/2025 at 17:05, 2 months 18 days ago First Berlin Reaffirms Buy Rating for Formycon AG BUY Rating Formycon AG Revenue Guidance Dupixent Keytruda Biosimilar
PRESS RELEASE published on 11/20/2025 at 17:00, 2 months 18 days ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation on Formycon AG (DE000A1EWVY8) to EUR 53 target price post Q3 results surpassing expectations and upcoming FYB206 study endpoint results First Berlin Equity Research Buy Recommendation Formycon AG FYB206 EUR 53 Target Price
BRIEF published on 11/20/2025 at 06:35, 2 months 19 days ago Lancement en Allemagne du biosimilaire de ranibizumab Epruvy® Formycon AG Ranibizumab Biosimilaire Lancement En Allemagne Soins Ophtalmiques
BRIEF published on 11/20/2025 at 06:35, 2 months 19 days ago Ranibizumab Biosimilar Epruvy® Launched in Germany Formycon AG Ranibizumab Biosimilar Germany Launch Ophthalmic Care
PRESS RELEASE published on 11/20/2025 at 06:30, 2 months 19 days ago Ranibizumab Biosimilar Epruvy® launched in Germany Ranibizumab Biosimilar Epruvy® launched in Germany by Formycon AG, Bioeq AG, and Sandoz AG under license agreement, expanding patient access to treatment options for nAMD and retinopathies Formycon AG Germany Ranibizumab Sandoz AG Epruvy
BRIEF published on 11/17/2025 at 06:35, 2 months 22 days ago Formycon Reaches Milestone with FYB208 for Dupixent® Biosimilars Formycon Chronic Inflammatory Diseases Dupilumab Technical Proof Of Similarity
BRIEF published on 11/17/2025 at 06:35, 2 months 22 days ago Formycon franchit une étape importante avec FYB208 pour Dupixent® Maladies Inflammatoires Chroniques Formycon Biosimilaires Dupilumab Preuve Technique De Similitude
Published on 02/09/2026 at 15:00, 1 hour 54 minutes ago Gungnir Resources Inc. Announces Management And Board Changes
Published on 02/09/2026 at 14:15, 2 hours 39 minutes ago White Gold Corp. Appoints Seasoned Mining Executive Donovan Pollitt as Strategic Advisor
Published on 02/09/2026 at 14:00, 2 hours 54 minutes ago Paymetrex Secures First U.S. License Payment
Published on 02/09/2026 at 14:00, 2 hours 54 minutes ago Geophysics Converge Ahead of Colosseum Deeper Drill Program
Published on 02/09/2026 at 13:00, 3 hours 54 minutes ago Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan
Published on 02/09/2026 at 15:47, 1 hour 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 02/09/2026 at 15:45, 1 hour 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Published on 02/09/2026 at 15:43, 1 hour 10 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 02/09/2026 at 14:49, 2 hours 4 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/09/2026 at 10:40, 6 hours 13 minutes ago Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 02/09/2026 at 08:30, 8 hours 24 minutes ago THERMADOR GROUPE : Plan to separate the roles of chairman and chief executive officer
Published on 02/09/2026 at 08:30, 8 hours 24 minutes ago THERMADOR GROUPE : Projet de séparation des mandats de président et directeur général
Published on 02/09/2026 at 08:00, 8 hours 54 minutes ago Eiffage renforce son expertise dans le secteur du froid industriel avec une prise de participation majoritaire dans l’entreprise française Quercy Réfrigération
